Evidence map›Paper›PMID 34197905›Full record

ArticleNeuroscience letters2021

Involvement of GRK2 in modulating nalfurafine-induced reduction of excessive alcohol drinking in mice.

Yan Zhou, Yupu Liang

Open access · greenAbstract read
In one paragraph

Article in Neuroscience letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yan ZhouLaboratory of the Biology of Addictive Diseases, USA. Electronic address: zhouya@rockefeller.edu.
Yupu LiangResearch Bioinformatics, CCTS, The Rockefeller University, NY, USA.
Rockefeller University · US

Funding

Role of hypothalamic-specific POMC deficiency in alcohol reward and drinkingR03AA021970 · NIAAA · ROCKEFELLER UNIVERSITY · PI ZHOU, YAN · 2015 to 2016
$170k
NIAAA NIH HHS R03 AA021970
6 · The paper itself

Abstract

Though it is well known that G protein-coupled receptor kinase 2 [GRK2] is involved in regulation of mu opioid receptor [MOR] desensitization and morphine-related behaviors, the potential role of GRK2 in regulation of kappa opioid receptor [KOR] functions in vivo has not been established yet. A couple of recent studies have found that GRK2 activity desensitizes KOR functions via decreasing G protein-coupled signaling with sensitizing arrestin-coupled signaling. Nalfurafine, a G protein-biased KOR full agonist, produces an inhibitory effect on alcohol intake in mice, with fewer side effects (sedation, aversion, or anxiety/depression-like behaviors). Using RNA sequencing (RNA-seq) analysis, we first identified that nuclear transcript level of grk2 [adrbk1] (but not other grks) was significantly up-regulated in mouse nucleus accumbens shell (NAcs) after chronic excessive alcohol drinking, suggesting alcohol specifically increased NAcs grk2 expression. We then tested whether selective GRK2/3 inhibitor CMPD101 could alter alcohol intake and found that CMPD101 alone had no effect on alcohol drinking. Therefore, we hypothesized that the grk2 increase in the NAcs could modulate the nalfurafine effect on alcohol intake via interacting with the G protein-mediated KOR signaling. Nalfurafine decreased alcohol drinking in a dose-related manner, and pretreatment with CMPD101 enhanced the reduction in alcohol intake induced by nalfurafine, indicating an involvement of GRK2/3 blockade in modulating G protein-biased KOR agonism of nalfurafine. Together, our study provides initial evidence relevant to the transcriptional change of grk2 gene in the NAc shell after excessive alcohol drinking. Pharmacological GRK2/3 blockade enhanced nalfurafine's efficacy, suggesting a GRK2/3-mediated mechanism, probably through the G protein-mediated KOR signaling.

Indexed as

AlcoholismAnimalsBenzamidesDisease Models, AnimalDrug SynergismDrug Therapy, CombinationEthanolG-Protein-Coupled Receptor Kinase 2G-Protein-Coupled Receptor Kinase 3HumansMaleMiceMorphinansNucleus AccumbensPyridinesReceptors, Opioid, kappaBenzamidesCMPD101EthanolG-Protein-Coupled Receptor Kinase 2G-Protein-Coupled Receptor Kinase 3GRK2 protein, mouseGRK3 protein, mouseMorphinansPyridinesReceptors, Opioid, kappaSpiro CompoundsTriazolesTRK 820CMPD101Excessive alcohol drinkingGrk2KOP-rNAc shellNalfurafineRNA-seq

Identifiers

PMID34197905
PMCPMC8355176
OpenAlexW3175530822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.